Financial Expert Ensures Proof of Reasonable Royalty in Unjust Enrichment Case

Business Valuation UpdateVol. 15 No. 4
Legal and Court Case Update
April 2009

Access the Full Article

This article is available with a subscription to any of these products:
It is also available in this product:
Already a subscriber or product owner?  Login
This article is also available for purchase. (920 words)   Add to Cart >>
Need help? Contact us:
1-503-479-8200 ext 2 or sales@bvresources.com
2834 Pharmaceutical Preparations
325412 Pharmaceutical Preparation Manufacturing
tort
Massachusetts Eye and Ear Infirmary v. QLT Phototherapeutics, Inc.
2009 WL 78064 (C.A. 1 (Mass.))
January 12, 2009
US
Federal Court
1st Circuit
United States Court of Appeals
Aaron M Panner, Christopher J Harnett, Donald R Ware, F Turner Buford, James F Haley, Jeff Bone, John D Donovan, Karen Mangasarian, Kenneth B Herman, Richard G Taranto, Sarah Cooleybeck
Howard

Summary

1st Circuit upholds 3% reasonable royalty rate award for defendant’s misappropriation of plaintiff’s confidential biotech research.

See Also

Massachusetts Eye and Ear Infirmary v. QLT Phototherapeutics, Inc.

Full Text of Court Cases
January 12, 2009

First Circuit upholds 3% reasonable royalty rate award for defendant’s misappropriation of plaintiff’s confidential biotech research.

This article also appears in:
Business Valuation UpdateVol. 15 No. 4
The Comprehensive Guide to Economic Damages, Seventh Edition